ASXL1 deletion
|
CML
|
ASXL1 deletion
|
CML
|
Tyrosine kinase inhibitor Resistant: C3 – Early Trials
|
Tyrosine kinase inhibitor Resistant: C3 – Early Trials
|
ASXL1 deletion
|
MDS
|
ASXL1 deletion
|
MDS
|
azacitidine Resistant: C3 – Early Trials
|
azacitidine Resistant: C3 – Early Trials
|